玻璃体视网膜疾病合并未控制青光眼患者在玻璃体切割术中进行睫状体光凝术。

Ciliary body endophotocoagulation during pars plana vitrectomy in eyes with vitreoretinal disorders and concomitant uncontrolled glaucoma.

作者信息

Lim J I, Lynn M, Capone A, Aaberg T M, Martin D F, Drews-Botsch C

机构信息

Department of Ophthalmology, Emory University School of Medicine, Atlanta, USA.

出版信息

Ophthalmology. 1996 Jul;103(7):1041-6. doi: 10.1016/s0161-6420(96)30569-1.

DOI:10.1016/s0161-6420(96)30569-1

PMID:8684792

Abstract

PURPOSE

To investigate the efficacy of ciliary body endophotocoagulation during pars plana vitrectomy in eyes with medically uncontrolled glaucoma and concomitant vitreoretinal disorders.

METHODS

The authors compared preoperative and postoperative intraocular pressure (IOP) and visual acuity in 21 eyes of 21 patients undergoing ciliary body endophotocoagulation with pars plana vitrectomy.

RESULTS

Preoperative IOPs ranged from 22 to 59 mmHg (median, 46 mmHg). Visual acuity ranged from 20/200 to light perception (median, hand motions). Follow-up ranged from 3 to 18 months (median, 10 months). Postoperative IOPs ranged from 11 to 19 mmHg (median, 16 mmHg) at 6 weeks, 4 to 20 mmHg (median, 14 mmHg) at 3 months, 1 to 26 mmHg (median, 12 mmHg) at 6 months, and 0 to 48 mmHg (median, 12 mmHg) at 12 months. Postoperative visual acuity was statistically improved from preoperative visual acuity by 6 weeks.

CONCLUSION

Ciliary body endophotocoagulation combined with pars plana vitrectomy can effectively treat concomitant glaucoma and vitreoretinal disorders.

摘要

目的

探讨在药物治疗无法控制的青光眼合并玻璃体视网膜疾病的眼中，经睫状体扁平部玻璃体切除术时进行睫状体光凝术的疗效。

方法

作者比较了21例接受睫状体扁平部玻璃体切除联合睫状体光凝术的患者21只眼的术前和术后眼压（IOP）及视力。

结果

术前眼压范围为22至59 mmHg（中位数为46 mmHg）。视力范围为20/200至光感（中位数为手动）。随访时间为3至18个月（中位数为10个月）。术后6周眼压范围为11至19 mmHg（中位数为16 mmHg），3个月时为4至20 mmHg（中位数为14 mmHg），6个月时为1至26 mmHg（中位数为12 mmHg），12个月时为0至48 mmHg（中位数为12 mmHg）。术后6周时，术后视力较术前视力有统计学意义的改善。